As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Wellness Genomics Market: By Type: Predictive Testing, Consumer Genomics, Others; By Setting Type: DTC, Professional; By Application: Breast and Ovarian Cancer Screening, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Wellness Genomics Market Outlook

The global wellness genomics market attained a value of USD 4 billion in 2020. The wellness genomics market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 14% to reach USD 8.8 billion by 2026.

 

The increased awareness of healthcare and the changing preferences of the population for a healthier lifestyle have contributed to the growth of the wellness genomics industry.

 

Global Wellness Genomics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Genomics or genome sequencing had been previously synonymous with the threat of a disease or more death. With genome sequencing becoming cheaper and more affordable, numerous bioinformatics companies offer services that use DNA-based information to treat ageing, manage or detect wellness, or even the sports a person must pursue in accordance with genetic information, and eventually attempt to combine a healthy approach to his life. Genetic data can be used for a substantially healthy life. This is now referred to as wellness genomics.

 

Global Wellness Genomics Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the wellness genomics market can be divided into predictive testing and consumer genomics.

Predictive testing can be further divided into:

  • Genetic Susceptibility Test
  • Predictive Diagnostics
  • Population Screening Programs

Consumer genomics is further segmented into:

  • Wellness Genetics
  • Nutria Genetics
  • Skin and Metabolism Genetics
  • Others

The setting type is divided into the following:

  • DTC
  • Professional

The wellness genomics market can be broadly categorised based on its applications into:

  • Breast and Ovarian Cancer Screening
  • Cardiovascular Screening
  • Diabetic Screening and Monitoring
  • Colon Cancer Screening
  • Alzheimer’s Disease
  • Prostate Cancer Screening
  • Orthopaedic and Musculoskeletal Screening
  • Other Cancer Screening
  • Other Diseases Screening

The EMR report looks into the regional wellness genomics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Wellness Genomics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

 

Market Analysis

The increased awareness of healthcare and the changing population preferences to a healthy lifestyle contributed to the growth of the predictive genetics research and the wellness genomics industry. The global genetic testing and wellness genomics market are expected to be driven by factors such as increased public and private regulatory attention to public health, improved genetic test efficacy and efficiency, the prevalence of genetically modified chronic diseases, and diseases such as Parkinson’s and cystic fibroids. In addition, the growing need to comprehend one’s family history also drives the global market. Strict regulatory regulations and ethics to allow genetic testing could, however, restrict the market growth.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global wellness genomics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories (NYSE: ABT)
  • Thermo Fisher Scientific, Inc. 
  • Agilent Technologies, Inc. 
  • Bio-Rad Laboratories, Inc. 
  • Illumina, Inc. 
  • Qiagen NV 
  • Myriad Genetics, Inc. 
  • Siemens AG 
  • Cooper Surgical, Inc. 
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraints
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Wellness Genomics Market Analysis
    6.1    Figure: Global Wellness Genomics Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Chart: Global Wellness Genomics Market Breakup by Type
        6.2.1    Predictive Testing
            6.2.1.1    Genetic Susceptibility Test
            6.2.1.2    Predictive Diagnostics
            6.2.1.3    Population Screening Programs
        6.2.2    Consumer Genomics
            6.2.2.1    Wellness Genetics
            6.2.2.2    Nutria Genetics
            6.2.2.3    Skin and Metabolism Genetics
        6.2.2.4    Others
    6.3    Figure: Global Wellness Genomics Market Breakup by Type: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Predictive Testing
            6.3.1.1    Genetic Susceptibility Test
            6.3.1.2    Predictive Diagnostics
            6.3.1.3    Population Screening Programs
        6.3.2    Consumer Genomics
            6.3.2.1    Wellness Genetics
            6.3.2.2    Nutria Genetics
            6.3.2.3    Skin and Metabolism Genetics
            6.3.2.4    Others
    6.4    Chart: Global Wellness Genomics Market Breakup by Setting Type
        6.4.1    DTC
        6.4.2    Professional
    6.5    Figure: Global Wellness Genomics Market Breakup by Setting Type: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    DTC
        6.5.2    Professional
    6.6    Chart: Global Wellness Genomics Market Breakup by Application
        6.6.1    Breast and Ovarian Cancer Screening
        6.6.2    Cardiovascular Screening
        6.6.3    Diabetic Screening & Monitoring
        6.6.4    Colon Cancer Screening
        6.6.5    Alzheimer’s Disease
        6.6.6    Prostate Cancer Screening
        6.6.7    Orthopaedic and Musculoskeletal Screening
        6.6.8    Other Cancer Screening
        6.6.9    Other Diseases Screening
    6.7    Figure: Global Wellness Genomics Market Breakup by Application: Historical Market (2016-2020) & Forecast (2021-2026)
        6.7.1    Breast and Ovarian Cancer Screening
        6.7.2    Cardiovascular Screening
        6.7.3    Diabetic Screening and Monitoring
        6.7.4    Colon Cancer Screening
        6.7.5    Alzheimer’s Disease
        6.7.6    Prostate Cancer Screening
        6.7.7    Orthopaedic and Musculoskeletal Screening
        6.7.8    Other Cancer Screening
        6.7.9    Other Diseases Screening
    6.8    Chart: Global Wellness Genomics Market Breakup by Region
        6.8.1    North America
            6.8.1.1    United States of America
            6.8.1.2    Canada
        6.8.2    Europe
            6.8.2.1    Germany
            6.8.2.2    France
            6.8.2.3    United Kingdom
            6.8.2.4    Italy
            6.8.2.5    Others
        6.8.3    Asia Pacific
            6.8.3.1    China
            6.8.3.2    Japan
            6.8.3.3    India
            6.8.3.4    ASEAN
            6.8.3.5    Others
        6.8.4    Latin America
            6.8.4.1    Brazil
            6.8.4.2    Argentina
            6.8.4.3    Mexico
            6.8.4.4    Others
        6.8.5    Middle East and Africa
            6.8.5.1    Saudi Arabia
            6.8.5.2    United Arab Emirates
            6.8.5.3    Nigeria
            6.8.5.4    South Africa
            6.8.5.5    Others
    6.9    Figure: Global Wellness Genomics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026) 
        6.9.1    North America
            6.9.1.1    United States of America
            6.9.1.2    Canada
        6.9.2    Europe
            6.9.2.1    Germany
            6.9.2.2    France
            6.9.2.3    United Kingdom
            6.9.2.4    Italy
            6.9.2.5    Others
        6.9.3    Asia Pacific
            6.9.3.1    China
            6.9.3.2    Japan
            6.9.3.3    India
            6.9.3.4    ASEAN
            6.9.3.5    Others
        6.9.4    Latin America
            6.9.4.1    Brazil
            6.9.4.2    Argentina
            6.9.4.3    Mexico
            6.9.4.4    Others
        6.9.5    Middle East and Africa
            6.9.5.1    Saudi Arabia
            6.9.5.2    United Arab Emirates
            6.9.5.3    Nigeria
            6.9.5.4    South Africa
            6.9.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis 
    9.1    F. Hoffmann-La Roche Ltd. (SWX: ROG)
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Abbott Laboratories (NYSE: ABT)
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Thermo Fisher Scientific, Inc. (NYSE: TMO)
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Agilent Technologies, Inc. (NYSE: A)
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Bio-Rad Laboratories, Inc. (NYSE: BIO)
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Illumina, Inc. (NASDAQ: ILMN)
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7    Qiagen NV (NYSE: QGEN)
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Myriad Genetics, Inc. (NASDAQ: MYGN)
        9.8.1    Company Overview
        9.8.2    Financial Analysis
    9.9    Siemens AG (ETR: SIE)
        9.9.1    Company Overview
        9.9.2    Financial Analysis
    9.10    Cooper Surgical, Inc. 
        9.10.1    Company Overview
        9.10.2    Financial Analysis
    9.11    Others
10    Industry Events and Development

Key Questions Answered in the Report

In 2020, the global wellness genomics market attained a value of nearly USD 4 billion.

The market is projected to grow at a CAGR of 14% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 8.8 billion by 2026.

The major drivers of the industry, such as the increased awareness of healthcare, changing population preferences to a healthy lifestyle, increased public and private regulatory attention to public health, improved genetic test efficacy and efficiency, and the prevalence of genetically modified chronic diseases and diseases such as Parkinson’s and cystic fibroids, are expected to aid the market growth.

The key market trend guiding the growth of the market includes the growing awareness regarding the comprehension of one’s family history.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading types of wellness genomics in the industry include predictive testing and consumer genomics.

The major setting types within the industry are DTC and professional.

The significant applications in the industry are breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Alzheimer’s disease, prostate cancer screening, orthopaedic and musculoskeletal screening, other cancer screening, and other diseases screening.

The major players in the industry are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen NV, Myriad Genetics, Inc., Siemens AG, and Cooper Surgical, Inc., among others.

Analyst Review

The global wellness genomics market attained a value of USD 4 billion in 2020, driven by the rising awareness of healthcare. Aided by the changing lifestyles to a healthier one, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 14%. The market is projected to reach USD 8.8 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the wellness genomics industry can be segmented into predictive testing and consumer genomics. On the basis of setting types, the industry is bifurcated into DTC and professional.  On the basis of applications, the industry is divided into breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Alzheimer’s disease, prostate cancer screening, orthopaedic and musculoskeletal screening, other cancer screening, and other diseases screening. The major regional markets for wellness genomics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen NV, Myriad Genetics, Inc., Siemens AG, Cooper Surgical, Inc., and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER